These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26817476)

  • 1. Good-quality research in rare diseases: trials and tribulations.
    Bolignano D; Pisano A
    Pediatr Nephrol; 2016 Nov; 31(11):2017-23. PubMed ID: 26817476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence.
    Bolignano D; Nagler EV; Van Biesen W; Zoccali C
    Nephrol Dial Transplant; 2014 Sep; 29(9):1628-32. PubMed ID: 24026240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Aymé S; Bockenhauer D; Day S; Devuyst O; Guay-Woodford LM; Ingelfinger JR; Klein JB; Knoers NVAM; Perrone RD; Roberts J; Schaefer F; Torres VE; Cheung M; Wheeler DC; Winkelmayer WC;
    Kidney Int; 2017 Oct; 92(4):796-808. PubMed ID: 28938953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the quality of reporting in randomised controlled trials.
    Walker A; Nixon J
    J Wound Care; 2004 Mar; 13(3):103-6. PubMed ID: 15045804
    [No Abstract]   [Full Text] [Related]  

  • 5. Redefining the randomized controlled trial in the context of acupuncture research.
    Walji R; Boon H
    Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size estimation for cluster randomized controlled trials.
    Ribeiro DC; Milosavljevic S; Abbott JH
    Musculoskelet Sci Pract; 2018 Apr; 34():108-111. PubMed ID: 29037472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trials: the meeting place of medical practice and clinical research.
    Hughes EG
    Semin Reprod Med; 2003 Feb; 21(1):55-64. PubMed ID: 12806560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the endocrine research pipeline broken? A systematic evaluation of the Endocrine Society clinical practice guidelines and trial registration.
    Singh Ospina N; Rodriguez-Gutierrez R; Brito JP; Young WF; Montori VM
    BMC Med; 2015 Aug; 13():187. PubMed ID: 26265226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methodological quality of an article on the treatment of gastric cancer adopted as protocol by some Chilean hospitals].
    Manterola C; Torres R; Burgos L; Vial M; Pineda V
    Rev Med Chil; 2006 Jul; 134(7):920-6. PubMed ID: 17130977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The randomized controlled trial: gold standard, or merely standard?
    Grossman J; Mackenzie FJ
    Perspect Biol Med; 2005; 48(4):516-34. PubMed ID: 16227664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-Based Medicine and Rare Diseases.
    Day S
    Adv Exp Med Biol; 2017; 1031():207-220. PubMed ID: 29214574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled trials: Gold or bronze?
    Cheng Hy
    J Am Med Dir Assoc; 2006 Nov; 7(9):611-2. PubMed ID: 17095430
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Study Designs and Sources of Error in Medical Research.
    Kacha AK; Nizamuddin SL; Nizamuddin J; Ramakrishna H; Shahul SS
    J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2789-2801. PubMed ID: 29571641
    [No Abstract]   [Full Text] [Related]  

  • 14. Size of treatment effects and their importance to clinical research and practice.
    Kraemer HC; Kupfer DJ
    Biol Psychiatry; 2006 Jun; 59(11):990-6. PubMed ID: 16368078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Structure of Research Questions in Randomized Controlled Trials in the Rehabilitation Field: A Methodological Study.
    Arienti C; Lazzarini SG; Patrini M; Puljak L; Pollock A; Negrini S
    Am J Phys Med Rehabil; 2021 Jan; 100(1):29-33. PubMed ID: 33031109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidenced based medicine. Benefits, limitations and issues for complementary and alternative medicine.
    Mendel J
    Aust J Holist Nurs; 2004 Oct; 11(2):21-9. PubMed ID: 19175254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can good randomized controlled trials in leading journals be so misinterpreted?
    Veith FJ
    J Vasc Surg; 2013 Feb; 57(2 Suppl):3S-7S. PubMed ID: 23336854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trials in nephrology: state of the evidence and critiquing the evidence.
    Samuels JA; Molony DA
    Adv Chronic Kidney Dis; 2012 Jan; 19(1):40-6. PubMed ID: 22364800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival distributions impact the power of randomized placebo-phase design and parallel groups randomized clinical trials.
    Abrahamyan L; Li CS; Beyene J; Willan AR; Feldman BM
    J Clin Epidemiol; 2011 Mar; 64(3):286-92. PubMed ID: 20926258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medicine and rare diseases.
    Day S
    Adv Exp Med Biol; 2010; 686():41-53. PubMed ID: 20824438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.